Time is running out to secure this ASX healthcare share dividend

Investors only have until the end of trading today to get hold of the latest Virtus Health dividend.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Virtus Health shares are edging into the red this afternoon
  • The company's shares are due to trade ex-dividend tomorrow
  • Eligible shareholders will receive a dividend payment of 12 cents per share on 14 April

The Virtus Health Ltd (ASX: VRT) share price is seesawing today. It has been down as low as $8.21 and as high as $8.27 but it is currently 0.12% in the red at $8.22.

This comes despite the fertility treatment company not releasing any price-sensitive announcements to the ASX today.

In comparison, the All Ordinaries Index (ASX: XAO) has shot up 1.17% to 7,647.6 points today.

So what's been happening with Virtus Health?

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.

Image source: Getty Images

Virtus Health shares set to go ex-dividend

Today is the last chance for investors to get their hands on the Virtus Health interim dividend.

Investors need to buy Virtus Health shares before market close today to be eligible for the interim dividend. The ex-dividend date is tomorrow, Wednesday 23 March.

It is worth noting that on the ex-dividend day, the share price traditionally falls in proportion to the dividend amount. This is because investors tend to sell off the company's shares after securing the dividend.

What does this mean for Virtus Health shareholders?

For those who are eligible for the Virtus Health interim dividend, shareholders will receive a payment of 12 cents per share on 14 April.

The dividend is also fully franked, which means shareholders can expect to receive tax credits from this.

Virtus Health share price summary

When looking at the past 12 months, the Virtus Health share price is up almost 40%. It is also up 20% this year to date.

The company's shares reached a 52-week high of $8.33 a little over a week ago. This came after the company announced it had signed a transaction implementation deed with an entity controlled by CapVest Partners. Under the deed, CapVest will acquire 100% of Virtus shares by a scheme of arrangement. 

Based on today's price, Virtus Health commands a market capitalisation of roughly $703.97 million and has a trailing dividend yield of 2.92%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Doctor analysing x-rays.
Healthcare Shares

4DMedical shares are rocketing 11% today. Is a short squeeze starting?

Short sellers may be feeling the heat after this week’s rally.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Shares surge as ASX biotech charts road to redemption

A recent major setback might not be so bad.

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Forget CSL shares, I'd buy this ASX biotech stock instead

Brokers tip this other ASX biotech stock to climb up to 76% higher.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused.
Healthcare Shares

CSL acknowledges "disappointing" results but aims to do better

The search for a new CEO also goes on.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

This sector is coming back into favour.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

4DMedical vs Telix Pharmaceuticals: ASX health tech share showdown

4DMedical and Telix are both Aussie health innovators—here’s which ASX share gets my vote in this biotech battle.

Read more »

cochlear happy, share price rise, up, increase
Healthcare Shares

Cochlear share price rebounds 53% from 10-year low: Can it keep climbing?

The shares are still down 47% for the year to date.

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

Two broker upgrades put CSL shares back in focus

CSL is back on the radar after two broker upgrades.

Read more »